Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04735406 · ClinicalTrials.gov registry record
The MS-LINK™ Outcomes Study
A clinical trial of Multiple Sclerosis, sponsored by EMD Serono Research & Development Institute.
- Completed
- Registry status
- 2,182
- Enrollment target
- 9
- Study locations
NCT04735406 is a study of Multiple Sclerosis that has completed, run by EMD Serono Research & Development Institute. The registered enrollment target is 2,182 participants, above the 578-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (278% higher). The trial reports 9 study locations across 8 states.
The verdict
NCT04735406, a study of Multiple Sclerosis, has completed, sponsored by EMD Serono Research & Development Institute.
- COMPLETED
- Registry status
- 2,182 participants
- Enrollment target
- 9
- Study locations
Study Summary
The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the study (currently 3 years), unless the participant chooses to withdraw from the study. Collection of participant's medical history, including MS and treatment history, will be automated through extraction from the participant's electronic medical record (EMR) and other health information systems (for example, radiology). Participants will complete patient-reported outcomes (PROs) and other health-related information digitally. Participating participants will have access to their own data in an ongoing manner via a web-based Participant Portal.
Conditions Studied
Study Locations (9)
Texas
- The University of Texas of Austin - Austin
- University of Texas Health - San Antonio
Alabama
- Alabama Neurology Associates - Birmingham
District of Columbia
- Georgetown University - Washington D.C.
Georgia
- Atlanta Neuroscience Institute - Atlanta
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Michigan
- Memorial healthcare - Owosso
Nebraska
- University of Nebraska medical Center - Omaha
Oklahoma
- The Oklahoma Medical Research Foundation - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,182 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2024-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04735406
The ClinicalTrials.gov registry entry for NCT04735406 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,182 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 578-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (278% higher). The listed sponsor is EMD Serono Research & Development Institute, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT04735406 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Texas, Alabama, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04735406 about?
NCT04735406 is a clinical study titled "The MS-LINK™ Outcomes Study". The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the stu...
What is the current status of trial NCT04735406?
This trial is currently completed. The enrollment target is 2,182 participants. The study started on 2021-03-24. Estimated completion is 2024-05-31.
What conditions does trial NCT04735406 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
Who is sponsoring clinical trial NCT04735406?
This trial is sponsored by EMD Serono Research & Development Institute, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04735406 being conducted?
This trial has 9 study locations across Alabama, District of Columbia, Georgia, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.